semaglutide weight loss graph results after 8 months on Chronic Weight Management Trial Results
Description
[DOI] [PubMed] [Google Scholar] 37.Capehorn MS, Catarig AM, Furberg JK, et al
Both are weekly injectable GLP-1-based treatments, but they are different active ingredients and should not be treated as interchangeable
Symptoms often relate to meal size, fat content, and eating pace , and many patients improve with time and behavioral adjustments
This increases the amount of time it takes for food to be digested and passed through the body
Given the substantial benefits of semaglutide and SGLT2 inhibitors, concurrent use may be considered in type 2 diabetes with chronic kidney disease. References: Mann JFE, et al
